TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26116933

Group type: EXPERIMENTAL
Intervention: Slow-oscillatory stimulation during sleep (0.75Hz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation during sleep
Number of subjects: 0
Study: 23983248

Group type: EXPERIMENTAL
Intervention: Aminoterminal propeptide of type III procollagen/type 1 collagen telopeptide ratio ≤1
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide >100 pg/mL
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: LV ejection fraction at discharge (per 5% increment)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: High brain natriuretic peptide and aminoterminal propeptide of type III procollagen/type 1 collagen telopeptide ratio ≤1
Number of subjects: 246
Study: 20878178

Group type: EXPERIMENTAL
Intervention: 0.5 g of alcohol per kg bodyweight (vodka and orange juice)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isocaloric, isovolumetric non-alcoholic beverage
Number of subjects: 10
Study: 19091990

Group type: EXPERIMENTAL
Intervention: NeisVac-C (MCC conjugated to tetanus toxoid)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Menjugate (MCC conjugated to CRM(197))
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Meningitec (MCC conjugated to CRM(197))
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Pediacel coadministered with NeisVac-C
Number of subjects: 393
Study: 17050927

Group type: EXPERIMENTAL
Intervention: 3% diclofenac in 2.5% hyaluronan gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (inactive gel vehicle, hyaluronan)
Number of subjects: 20
Study: 12628864

Group type: EXPERIMENTAL
Intervention: Nasal CPAP
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nasal CPAP with oral device
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oral CPAP
Number of subjects: 7
Study: 10683506

Group type: EXPERIMENTAL
Intervention: Acupuncture at earpoint (Lu 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acupuncture at thenar muscle (LI 4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Superficial needle insertion into skin overlying Hegu point
Number of subjects: 12
Study: 9118652

Group type: EXPERIMENTAL
Intervention: Dobutamine infusion at 10 micrograms/kg/min
Number of subjects: 14
Study: 7681656

Group type: EXPERIMENTAL
Intervention: Poly(I):poly(C12U) 600 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Poly(I):poly(C12U) 200 mg
Number of subjects: 14
Study: 30922990

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium (both doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28982815

Group type: EXPERIMENTAL
Intervention: E‐health module embedded in Collaborative Occupational healthcare (ECO)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual sickness guidance
Number of subjects: 220
Study: 25444805

Group type: EXPERIMENTAL
Intervention: 2009-H1N1 vaccine + Placebo
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: H1N1 vaccine + IIV3 + Placebo
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: H1N1 vaccine + Placebo + IIV3
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: IIV3 + Placebo + H1N1
Number of subjects: 805

Group type: COMPARATOR
Intervention: IIV3
Number of subjects: 805
Study: 22841362

Group type: EXPERIMENTAL
Intervention: SP assessments with SP feedback and group discussion
Number of subjects: 0

Group type: COMPARATOR
Intervention: SP assessments only
Number of subjects: 0
Study: 21980993

Group type: COMPARATOR
Intervention: Dehydration in a warm environment (DE-W)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dehydration in a thermoneutral environment (DE-T)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Euhydration in a warm environment (EU-W)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Euhydration in a thermoneutral environment (EU-T)
Number of subjects: 7
Study: 19164393

Group type: EXPERIMENTAL
Intervention: Acute geriatric units
Number of subjects: 11
Study: 17112849

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC-MPS)
Number of subjects: 197
Study: 14975468

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 2457
Study: 11829043

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation training (PMRT) - 20-min set of audiotaped instructions for home practice.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned).
Number of subjects: 18
Study: 9460399

Group type: EXPERIMENTAL
Intervention: Numerical Rating Scale (NRS)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Word Descriptor Scale (WDS)
Number of subjects: 116
Study: 7929921

Group type: EXPERIMENTAL
Intervention: Calcipotriene ointment 0.005%
Number of subjects: 114

Group type: COMPARATOR
Intervention: Fluocinonide ointment 0.05%
Number of subjects: 114
Study: 3074457

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrate bismuthate (TDB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 100
Study: 29722841

Group type: EXPERIMENTAL
Intervention: Meat complementary food group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Dairy complementary food group
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 26936312

Group type: EXPERIMENTAL
Intervention: Infant Behavioral Assessment and Intervention Program
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 176
Study: 26535884

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 146

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 146
Study: 24308572

Group type: EXPERIMENTAL
Intervention: Group-based nutrition education
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral methods applied to improved eating
Number of subjects: 294
Study: 19996786

Group type: EXPERIMENTAL
Intervention: Weighted sled (WS) group towing 10% body mass (n = 7)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Weighted vest (WV) group loaded with 18.5% body mass (n = 6)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unresisted (UR) active control group (n = 7)
Number of subjects: 20
Study: 18476415

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES) applied from 30 min before anesthesia to the end of operation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no TAES)
Number of subjects: 50
Study: 16645132

Group type: EXPERIMENTAL
Intervention: Interdisciplinary stroke team support at discharge
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard aftercare (control)
Number of subjects: 198
Study: 14702930

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy in outpatients (Group A)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy in in-patients (Group B)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Overall endoscopic sphincterotomy
Number of subjects: 124
Study: 11239618

Group type: EXPERIMENTAL
Intervention: Misoprostol 800 microg vaginally, administered at home 24 hours after mifepristone.
Number of subjects: 2747

Group type: COMPARATOR
Intervention: Misoprostol 800 microg vaginally, administered at home 48 hours after mifepristone.
Number of subjects: 2747

Group type: COMPARATOR
Intervention: Misoprostol 800 microg vaginally, administered at home 72 hours after mifepristone.
Number of subjects: 2747
Study: 8866546

Group type: EXPERIMENTAL
Intervention: Health Screening System (HSS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Paper-and-pencil format
Number of subjects: 22
Study: 1627763

Group type: EXPERIMENTAL
Intervention: Epoetin beta administered intravenously (i.v.) three times a week for at least 12 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epoetin beta administered intravenously (i.v.) once a week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epoetin beta administered subcutaneously (s.c.) once a week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epoetin beta administered subcutaneously (s.c.) with two doses per week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subcutaneous dosing two or three times a week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subcutaneous dosing
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intravenous dosing
Number of subjects: 36
Study: 6485738

Group type: EXPERIMENTAL
Intervention: 1% enflurane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.7% isoflurane
Number of subjects: 20
Study: 31544230

Group type: EXPERIMENTAL
Intervention: Single dose of 24 mg intravenous dexamethasone (DXM)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Two consecutive doses of 24 mg intravenous dexamethasone (DXM)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study: 30762779

Group type: EXPERIMENTAL
Intervention: Pro-Kin visual feedback balance training system
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional gait rehabilitation training
Number of subjects: 56
Study: 28525303

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with diode laser 830 nm
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 213
Study: 26019694

Group type: EXPERIMENTAL
Intervention: Garlic (900 mg powdered garlic)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24316697

Group type: EXPERIMENTAL
Intervention: Bromelain 150mg per day for three days and 100mg on days 4 to 7
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo in the same dosage as Bromelain
Number of subjects: 34
Study: 23023471

Group type: EXPERIMENTAL
Intervention: Watching Barney cartoon (in Spanish or English) for younger children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Watching Tarzan cartoon (in Spanish or English) for older children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified, but implied no cartoon viewing)
Number of subjects: 0
Study: 19720922

Group type: EXPERIMENTAL
Intervention: Plerixafor (240 microg/kg) plus G-CSF (10 microg/kg)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo plus G-CSF (10 microg/kg)
Number of subjects: 298
Study: 17728532

Group type: EXPERIMENTAL
Intervention: Respimat SMI pH 2.7
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Respimat SMI pH 7.0
Number of subjects: 32

Group type: COMPARATOR
Intervention: CFC-MDI
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Respimat SMI pH 3.4
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 32
Study: 15504287

Group type: EXPERIMENTAL
Intervention: Secretory human interferon alpha-2a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary interferon
Number of subjects: 0
Study: 11763937

Group type: EXPERIMENTAL
Intervention: Crest Cavity Fighting Toothpaste with Fluoristat (0.243% sodium fluoride)
Number of subjects: 2479

Group type: COMPARATOR
Intervention: Colgate Great Regular Flavor Fluoride Toothpaste (0.76% sodium monofluorophosphate)
Number of subjects: 2479
Study: 9279175

Group type: EXPERIMENTAL
Intervention: Aggressive nutritional regimen (group A)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Conservative nutritional regimen (group B)
Number of subjects: 125
Study: 8326972

Group type: EXPERIMENTAL
Intervention: Pilocarpine 5 mg orally three times a day for 12 weeks
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Pilocarpine 10 mg orally three times a day for 12 weeks
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 3551671

Group type: EXPERIMENTAL
Intervention: Saline nebulization (2 ml saline t.i.d.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bromhexine nebulization (2 ml bromhexine, 2 mg/ml t.i.d.)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Saline nebulization
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bromhexine nebulization
Number of subjects: 20
Study: 30720795

Group type: EXPERIMENTAL
Intervention: Education-based intervention program
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 464
Study: 27250851

Group type: EXPERIMENTAL
Intervention: High-intensity interval training three times per week for 10 weeks before assisted fertilization
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care assisted fertilization only
Number of subjects: 140
Study: 24519745

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1175

Group type: EXPERIMENTAL
Intervention: Written Materials (WM)
Number of subjects: 1175

Group type: EXPERIMENTAL
Intervention: Videocassette and Written Materials (VC)
Number of subjects: 1175
Study: 23252004

Group type: EXPERIMENTAL
Intervention: Obese patients (BMI 28.0 kg/m2)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Normal weight patients (18.5 kg/m2 < or = BMI < 24.0 kg/m2)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Overweight patients (24.0 kg/m2 < or = BMI < 28.0 kg/m2)
Number of subjects: 421
Study: 21268547

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg (E250)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Erythromycin 500 mg (E500)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg (M)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ondansetron 4 mg (Z)
Number of subjects: 80
Study: 18687718

Group type: EXPERIMENTAL
Intervention: Clomifene citrate
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Unstimulated intrauterine insemination
Number of subjects: 580

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 580
Study: 15804445

Group type: EXPERIMENTAL
Intervention: Ongoing oscillations between 3 and 16 Hz
Number of subjects: 0
Study: 12576259

Group type: EXPERIMENTAL
Intervention: Gabapentin 900 mg per day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Open-label gabapentin dosing (up to 2,700 mg per day)
Number of subjects: 59
Study: 10738641

Group type: EXPERIMENTAL
Intervention: Vincamine test product (60 mg single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vincamine reference product (60 mg single dose)
Number of subjects: 16
Study: 8646829

Group type: EXPERIMENTAL
Intervention: Twice-a-day regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three-times-a-day regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall compliance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doses taken at prescribed frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doses taken at prescribed intervals
Number of subjects: 0
Study: 2056895

Group type: COMPARATOR
Intervention: Ultrasound treatment at 0.0 W.cm‐2
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment at 1.5 W.cm‐2, pulsed 50%
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment at 1.5 W.cm‐2, continuous
Number of subjects: 7
Study: 6405876

Group type: EXPERIMENTAL
Intervention: 400 mg acebutolol combined with 12.5 mg hydrochlorothiazide
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 400 mg acebutolol combined with 25 mg hydrochlorothiazide
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 400 mg acebutolol combined with 50 mg hydrochlorothiazide
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Increasing doses of hydrochlorothiazide
Number of subjects: 2
Study: 31090674

Group type: EXPERIMENTAL
Intervention: 12-week dietary intervention monitored by health professionals
Number of subjects: 102
Study: 29572674

Group type: EXPERIMENTAL
Intervention: Adjuvant fractionated radiotherapy (RT)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Adjuvant fractionated RT and chemotherapy
Number of subjects: 555

Group type: COMPARATOR
Intervention: Non-adjuvant treatment
Number of subjects: 555
Study: 26929219

Group type: EXPERIMENTAL
Intervention: Tocilizumab infusions at 4-week intervals (3 infusions total) followed by oral prednisone from weeks 12 to 24 (0.15 mg/kg if PMR-AS ≤10 and 0.30 mg/kg otherwise)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tocilizumab infusions
Number of subjects: 20
Study: 25227538

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) with standard rehabilitation (SR)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard rehabilitation (SR)
Number of subjects: 37
Study: 23019949

Group type: EXPERIMENTAL
Intervention: Jing'an Oral Liquid (JOL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tiapride Tablet (TT)
Number of subjects: 60
Study: 20500251

Group type: EXPERIMENTAL
Intervention: Multimedia Learning Education Program (MLEP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no MLEP)
Number of subjects: 58
Study: 17935230

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (2 mg/kg/day from day 7 to day 21 and 1 mg/kg/day from day 22 to day 28)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 71
Study: 15598455

Group type: EXPERIMENTAL
Intervention: Dynamic radiostereometry during weight-bearing active extension in OA patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (10 controls)
Number of subjects: 24
Study: 11895960

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (2 x 10^8 CFU)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (CeraVacx buffer)
Number of subjects: 59
Study: 9462488

Group type: EXPERIMENTAL
Intervention: Nicotine patch for 10 weeks as an adjunct to brief counseling
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 410
Study: 7637364

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy plus dipyridamole (225 to 400 mg per day)
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Anticoagulant therapy alone
Number of subjects: 1141

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy plus dipyridamole
Number of subjects: 1141
Study: 2087819

Group type: EXPERIMENTAL
Intervention: Information booklet about endoscopic investigations
Number of subjects: 379

Group type: COMPARATOR
Intervention: No information booklet (control group)
Number of subjects: 379
Study: 6218101

Group type: EXPERIMENTAL
Intervention: mezlocillin plus sisomicin (Regimen A)
Number of subjects: 49

Group type: COMPARATOR
Intervention: cefamandole plus tobramycin (Regimen B)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: empiric Regimen C (cefotaxime plus amikacin plus azlocillin)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: antibiotics selected on the basis of bacteriological results (Regimen D)
Number of subjects: 49
Study: 31104217

Group type: EXPERIMENTAL
Intervention: Diacerein
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28864483

Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical spine immobilisation
Number of subjects: 0
Study: 27748671

Group type: EXPERIMENTAL
Intervention: iTBS at 80% resting motor threshold (RMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: iTBS at 40% resting motor threshold (RMT)
Number of subjects: 0
Study: 24635872

Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P: Positive Parenting Program (SSTP) with Acceptance and Commitment Therapy (ACT) workshop
Number of subjects: 59

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 59
Study: 23031082

Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Open donor nephrectomy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Recipients with delayed graft function
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Recipients without delayed graft function
Number of subjects: 200
Study: 19650919

Group type: EXPERIMENTAL
Intervention: Community health promotion campaign and education through health clubs, intensive training and mentoring of village health workers, improved outreach services.
Number of subjects: 146
Study: 17501846

Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 72
Study: 16941337

Group type: COMPARATOR
Intervention: Acute treatment (HAART initiated within 2 weeks of seroconversion)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Early treatment (HAART initiated between 2 weeks and 6 months after seroconversion)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Untreated group (no HAART)
Number of subjects: 395
Study: 12860535

Group type: EXPERIMENTAL
Intervention: 1.5% lidocaine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 13
Study: 10896032

Group type: EXPERIMENTAL
Intervention: Zolpidem (10mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5mg)
Number of subjects: 9
Study: 9034935

Group type: EXPERIMENTAL
Intervention: IFN plus UDCA
Number of subjects: 52

Group type: COMPARATOR
Intervention: IFN alone
Number of subjects: 52
Study: 1991274

Group type: EXPERIMENTAL
Intervention: Yearly chest radiography plus sputum cytology every 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yearly chest radiography only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advice to obtain chest radiography and sputum cytology once a year
Number of subjects: 0
Study: 6338415

Group type: EXPERIMENTAL
Intervention: Metrizamide (Amipaque)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iopamidol (Niopam)
Number of subjects: 100
Study: 30327396

Group type: EXPERIMENTAL
Intervention: Proficiency-based progression (PBP) training (Group P)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Simulation only training (Group S)
Number of subjects: 17
Study: 27498099

Group type: EXPERIMENTAL
Intervention: Monthly module group
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Weekly module group
Number of subjects: 492

Group type: COMPARATOR
Intervention: Single module group
Number of subjects: 492
Study: 23968289

Group type: EXPERIMENTAL
Intervention: Group A (window outlining technique)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Group B (ultrasonic erosion technique)
Number of subjects: 72